company background image
A099

i-SENS KOSDAQ:A099190 Stock Report

Last Price

₩31.00k

Market Cap

₩422.0b

7D

7.3%

1Y

12.1%

Updated

05 May, 2022

Data

Company Financials +
A099190 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance1/6
Financial Health4/6
Dividends2/6

A099190 Stock Overview

i-SENS, Inc. provides diagnostic biosensors in South Korea.

Price History & Performance

Summary of all time highs, changes and price drops for i-SENS
Historical stock prices
Current Share Price₩31,000.00
52 Week High₩38,550.00
52 Week Low₩25,800.00
Beta0.44
1 Month Change3.85%
3 Month Change7.83%
1 Year Change12.12%
3 Year Change27.57%
5 Year Change4.91%
Change since IPO79.19%

Recent News & Updates

May 07
Estimating The Fair Value Of i-SENS, Inc. (KOSDAQ:099190)

Estimating The Fair Value Of i-SENS, Inc. (KOSDAQ:099190)

In this article we are going to estimate the intrinsic value of i-SENS, Inc. ( KOSDAQ:099190 ) by taking the expected...

Shareholder Returns

A099190KR Medical EquipmentKR Market
7D7.3%0.4%0.6%
1Y12.1%-8.1%-13.9%

Return vs Industry: A099190 exceeded the KR Medical Equipment industry which returned -8.1% over the past year.

Return vs Market: A099190 exceeded the KR Market which returned -13.9% over the past year.

Price Volatility

Is A099190's price volatile compared to industry and market?
A099190 volatility
A099190 Average Weekly Movement4.7%
Medical Equipment Industry Average Movement6.2%
Market Average Movement5.5%
10% most volatile stocks in KR Market10.5%
10% least volatile stocks in KR Market3.2%

Stable Share Price: A099190 is not significantly more volatile than the rest of KR stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: A099190's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2000697Geun-Sig Chahttps://www.i-sens.com

i-SENS, Inc. provides diagnostic biosensors in South Korea. The company offers point of care testing devices, such as HbA1c, blood gas, electrolyte, and PT/INR analyzers; CareSens blood glucose monitoring systems; and lancing and other ancillary devices, as well as diabetes management services. It exports its products to approximately 110 countries, including the United States, Japan, and Europe.

i-SENS Fundamentals Summary

How do i-SENS's earnings and revenue compare to its market cap?
A099190 fundamental statistics
Market Cap₩421.96b
Earnings (TTM)₩25.45b
Revenue (TTM)₩232.93b

16.6x

P/E Ratio

1.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
A099190 income statement (TTM)
Revenue₩232.93b
Cost of Revenue₩130.87b
Gross Profit₩102.06b
Other Expenses₩76.61b
Earnings₩25.45b

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)1.87k
Gross Margin43.82%
Net Profit Margin10.93%
Debt/Equity Ratio34.7%

How did A099190 perform over the long term?

See historical performance and comparison

Dividends

1.0%

Current Dividend Yield

16%

Payout Ratio

Valuation

Is i-SENS undervalued compared to its fair value and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


16.58x

Price to Earnings (PE) ratio

Share Price vs. Fair Value

Below Fair Value: A099190 (₩31000) is trading above our estimate of fair value (₩6799.1)

Significantly Below Fair Value: A099190 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: A099190 is poor value based on its PE Ratio (16.6x) compared to the KR Medical Equipment industry average (13.1x).

PE vs Market: A099190 is poor value based on its PE Ratio (16.6x) compared to the KR market (14.8x).


Price to Earnings Growth Ratio

PEG Ratio: A099190 is good value based on its PEG Ratio (0.7x)


Price to Book Ratio

PB vs Industry: A099190 is good value based on its PB Ratio (1.6x) compared to the KR Medical Equipment industry average (2.7x).


Future Growth

How is i-SENS forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

Future Growth Score

4/6

Future Growth Score 4/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


22.5%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: A099190's forecast earnings growth (22.5% per year) is above the savings rate (3.5%).

Earnings vs Market: A099190's earnings (22.5% per year) are forecast to grow faster than the KR market (15.3% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: A099190's revenue (10.6% per year) is forecast to grow faster than the KR market (9.8% per year).

High Growth Revenue: A099190's revenue (10.6% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: A099190's Return on Equity is forecast to be low in 3 years time (13.8%).


Past Performance

How has i-SENS performed over the past 5 years?

Past Performance Score

1/6

Past Performance Score 1/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


11.2%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: A099190 has a high level of non-cash earnings.

Growing Profit Margin: A099190's current net profit margins (10.9%) are lower than last year (13.2%).


Past Earnings Growth Analysis

Earnings Trend: A099190's earnings have grown by 11.2% per year over the past 5 years.

Accelerating Growth: A099190's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: A099190 had negative earnings growth (-5.2%) over the past year, making it difficult to compare to the Medical Equipment industry average (30.5%).


Return on Equity

High ROE: A099190's Return on Equity (8.8%) is considered low.


Financial Health

How is i-SENS's financial position?

Financial Health Score

4/6

Financial Health Score 4/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: A099190's short term assets (₩207.7B) exceed its short term liabilities (₩38.4B).

Long Term Liabilities: A099190's short term assets (₩207.7B) exceed its long term liabilities (₩106.0B).


Debt to Equity History and Analysis

Debt Level: A099190 has more cash than its total debt.

Reducing Debt: A099190's debt to equity ratio has increased from 23.1% to 34.7% over the past 5 years.

Debt Coverage: A099190's debt is not well covered by operating cash flow (17.4%).

Interest Coverage: A099190 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is i-SENS current dividend yield, its reliability and sustainability?

Dividend Score

3/6

Dividend Score 3/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


0.97%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: A099190's dividend (0.97%) is higher than the bottom 25% of dividend payers in the KR market (0.82%).

High Dividend: A099190's dividend (0.97%) is low compared to the top 25% of dividend payers in the KR market (2.67%).


Stability and Growth of Payments

Stable Dividend: Whilst dividend payments have been stable, A099190 has been paying a dividend for less than 10 years.

Growing Dividend: A099190's dividend payments have increased, but the company has only paid a dividend for 3 years.


Earnings Payout to Shareholders

Earnings Coverage: With its low payout ratio (16%), A099190's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: A099190 is paying a dividend but the company has no free cash flows.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Geun-Sig Cha (67 yo)

2.33yrs

Tenure

Dr. Geun-Sig Cha serves as Chairman of the Board of i-SENS Inc. since 2020. Dr. Cha founded i-SENS, Inc., in May 4, 2000 and serves as its Chief Executive Officer since 2000. Dr. Cha serves as an Advisor o...


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

i-SENS, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: i-SENS, Inc.
  • Ticker: A099190
  • Exchange: KOSDAQ
  • Founded: 2000
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: ₩421.958b
  • Shares outstanding: 13.61m
  • Website: https://www.i-sens.com

Number of Employees


Location

  • i-SENS, Inc.
  • 43, Banpo-daero 28-gil
  • Seocho-gu
  • Seoul
  • 6646
  • South Korea

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/05 00:00
End of Day Share Price2022/05/04 00:00
Earnings2021/12/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.